The North America Genotyping Market is expected to witness market growth of 14.2% CAGR during the forecast period (2022-2028).
Genotyping with single-nucleotide polymorphism identifiers is currently frequently employed in small grain cereal genetic research and breeding. An almost limitless supply of SNP markers has been available due to various technologies such as the scanning of specific portions of the genome, such as transcribed sequences, or the resequencing of variety and lines.
Many samples are now routinely genotyped, especially within the context of genomic selection (GS), employing two distinct approaches such as genotyping-by-sequencing (GBS) and array-based genotyping with predetermined marker sets. Array-based genotyping in tiny grain breeding is evolving from pricey big arrays to smaller, freshly created second-generation arrays. Markers for specific phenotypes, along with high-quality polymorphic markers that are equally dispersed across the chromosomes and have little ascertainment bias, are included in such arrays.
Depending on a log-likelihood proportion calculation, genotype clusters are additionally categorized as non, a medium alert, or high alert. When compared to the concentration of the genotype across the country, alert levels reflect the degree of geographic intensity of cases in the same county or township area. American Indian or Alaska Native people and Native Hawaiian or Other Pacific Islander people continue to have the highest percentages of genotype-clustered cases.
The biggest number of clustered instances were seen among Hispanic or Latino people and non-Hispanic Black or African American people. The number of county-based clusters decreased by 5.3 percent from 1,351 in previous year's cases reported nationally from 2017 to 2019 to 1,280 in 2018-2020.
Universal TB genotyping entails sending at least one isolate to genotyping laboratories for every civilization TB patient in the country. The best understanding of the epidemiology of tuberculosis transmission inside a single TB program's jurisdiction, as well as across the country, is expected to come from universal TB genotyping.
The US market dominated the North America Genotyping Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $8,381.6 million by 2028. The Canada market is estimated to grow at a CAGR of 16.8% during (2022 - 2028). Additionally, The Mexico market is expected to showcase a CAGR of 15.8% during (2022 - 2028).
Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.
Genotyping with single-nucleotide polymorphism identifiers is currently frequently employed in small grain cereal genetic research and breeding. An almost limitless supply of SNP markers has been available due to various technologies such as the scanning of specific portions of the genome, such as transcribed sequences, or the resequencing of variety and lines.
Many samples are now routinely genotyped, especially within the context of genomic selection (GS), employing two distinct approaches such as genotyping-by-sequencing (GBS) and array-based genotyping with predetermined marker sets. Array-based genotyping in tiny grain breeding is evolving from pricey big arrays to smaller, freshly created second-generation arrays. Markers for specific phenotypes, along with high-quality polymorphic markers that are equally dispersed across the chromosomes and have little ascertainment bias, are included in such arrays.
Depending on a log-likelihood proportion calculation, genotype clusters are additionally categorized as non, a medium alert, or high alert. When compared to the concentration of the genotype across the country, alert levels reflect the degree of geographic intensity of cases in the same county or township area. American Indian or Alaska Native people and Native Hawaiian or Other Pacific Islander people continue to have the highest percentages of genotype-clustered cases.
The biggest number of clustered instances were seen among Hispanic or Latino people and non-Hispanic Black or African American people. The number of county-based clusters decreased by 5.3 percent from 1,351 in previous year's cases reported nationally from 2017 to 2019 to 1,280 in 2018-2020.
Universal TB genotyping entails sending at least one isolate to genotyping laboratories for every civilization TB patient in the country. The best understanding of the epidemiology of tuberculosis transmission inside a single TB program's jurisdiction, as well as across the country, is expected to come from universal TB genotyping.
The US market dominated the North America Genotyping Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $8,381.6 million by 2028. The Canada market is estimated to grow at a CAGR of 16.8% during (2022 - 2028). Additionally, The Mexico market is expected to showcase a CAGR of 15.8% during (2022 - 2028).
Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Reagents & Kits
- Instruments
- Software & Services
By Application
- Reagents & Kits
- Instruments
- Software & Services
By End Use
- Diagnostics & Research Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Academic Institutes
- Others
By Technology
- PCR
- Sequencing
- Capillary Electrophoresis
- Microarray
- Mass Spectrometry
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Fluidigm Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Genotyping Market by Product
Chapter 5. North America Genotyping Market by Application
Chapter 6. North America Genotyping Market by End Use
Chapter 7. North America Genotyping Market by Technology
Chapter 8. North America Genotyping Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Fluidigm Corporation
Methodology
LOADING...
